StrategIQ Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | $681K | Buy |
5,013
+422
| +9% | +$57.3K | 0.08% | 182 |
|
2023
Q3 | $561K | Buy |
4,591
+60
| +1% | +$7.34K | 0.07% | 196 |
|
2023
Q2 | $575K | Sell |
4,531
-80
| -2% | -$10.2K | 0.07% | 197 |
|
2023
Q1 | $596K | Sell |
4,611
-5
| -0.1% | -$646 | 0.07% | 177 |
|
2022
Q4 | $606K | Sell |
4,616
-120
| -3% | -$15.8K | 0.07% | 176 |
|
2022
Q3 | $554K | Buy |
4,736
+275
| +6% | +$32.2K | 0.07% | 177 |
|
2022
Q2 | $525K | Buy |
4,461
+2,841
| +175% | +$334K | 0.06% | 181 |
|
2022
Q1 | $211K | Buy |
1,620
+10
| +0.6% | +$1.3K | 0.02% | 282 |
|
2021
Q4 | $246K | Buy |
1,610
+233
| +17% | +$35.6K | 0.02% | 268 |
|
2021
Q3 | $223K | Hold |
1,377
| – | – | 0.04% | 206 |
|
2021
Q2 | $225K | Buy |
1,377
+31
| +2% | +$5.07K | 0.04% | 203 |
|
2021
Q1 | $203K | Buy |
+1,346
| New | +$203K | 0.04% | 203 |
|